Is Medical Cannabis Legal in the UK?

On 1 November 2018, the Home Secretary amended the Misuse of Drugs Regulations 2001, moving cannabis-based medicinal products (CBPMs) from Schedule 1 to Schedule 2. Schedule 1 drugs are those with no accepted medical use and cannot be prescribed. Schedule 2 drugs have recognised medical uses and can be prescribed by authorised persons — in the case of CBPMs, doctors on the GMC Specialist Register.

This change followed high-profile cases, most notably those of Billy Caldwell and Alfie Dingley, both children with severe epilepsy whose families campaigned publicly for access to cannabis-based medicines. The Advisory Council on the Misuse of Drugs (ACMD) recommended the rescheduling following a review of the evidence.

The rescheduling did not change the status of recreational cannabis. Cannabis for non-medical purposes remains a Class B drug under the Misuse of Drugs Act 1971, with penalties for possession, supply, and production unchanged.

A valid prescription for a cannabis-based medicinal product from a GMC-registered specialist gives you a legal right to possess that medication in the quantities prescribed. You are not committing any offence under the Misuse of Drugs Act 1971 by possessing a prescribed CBPM.

Practical points: - Always carry your prescription documentation or a letter from your prescribing clinic when you have your medication with you - This is particularly important during police stops, travel, or if questioned at any official checkpoint - Keep medication in its original dispensing packaging where possible - Do not share your medication — this is an offence under the Misuse of Drugs Act regardless of your prescription status

This is the area that causes most concern for patients, and it is important to understand it clearly.

Under Section 5A of the Road Traffic Act 1988, it is an offence to drive with certain controlled drugs in your body above specified limits. For THC (delta-9-tetrahydrocannabinol), the legal limit in England, Wales, and Scotland is 2 micrograms per litre of blood — a very low threshold designed to catch recreational users the morning after use.

However, there is a medical defence: Section 5A(3) provides a defence where the drug was lawfully prescribed and taken in accordance with medical advice, and where driving was not impaired.

What this means in practice: - You must not drive if you feel impaired after taking your medication — the impairment offence (Section 4 of the Road Traffic Act) applies regardless of any prescription - THC can remain detectable in blood for hours after its effects have worn off — timing matters - CBD-only products do not contain THC and do not trigger Section 5A limits - Discuss your specific medication and driving with your prescribing specialist — they can advise on timing and whether driving is advisable for your particular prescription

This is an area where patients must exercise extreme caution. A UK medical cannabis prescription does not give you the right to possess cannabis in another country.

Cannabis laws vary enormously across the world. Even countries that have their own medical cannabis programmes will not necessarily recognise a UK prescription. Carrying cannabis-based medicines abroad without the appropriate documentation for that country could result in serious criminal charges.

Key rules: - Do not travel internationally with cannabis-based medicines unless you have specifically researched and obtained the correct permits for the destination country - Some countries have a process for importing medicines for personal use — this requires advance notification to customs authorities in both the UK and the destination country - EU countries in particular have specific requirements that have changed since Brexit - Travel within the UK (including to Northern Ireland) with a prescribed CBPM is legal

If you need your medication while travelling, consult both the Home Office guidance on travelling with controlled drugs and the embassy of the destination country before you travel. Your prescribing clinic may also be able to advise.

There is currently no specific legal protection in UK employment law for medical cannabis patients. Whether your employer can take action based on a positive drug test or disclosed prescription depends on their policies, your role, and the outcome of any Equality Act 2010 considerations.

Important points: - Most standard workplace drug tests detect THC metabolites, which can remain in urine for days to weeks depending on frequency of use and metabolism - A positive test does not mean you were impaired at work — but many employer policies are zero-tolerance regardless - In safety-critical roles (operating heavy machinery, transport, healthcare), extra caution is required and disclosure to occupational health is strongly advisable - Your employer may have a duty under the Equality Act to make reasonable adjustments if your underlying condition is a disability and your medication is prescribed — but this does not guarantee protection from a positive drug test outcome - If you are a driver by profession or operate machinery, discuss the implications of your prescription with your specialist before starting treatment

Disclosure to your employer is a personal decision. Consulting an employment lawyer before disclosing in safety-critical roles is advisable.

It is important to be clear: purchasing cannabis without a prescription — whether from a dealer, an online store, or a "dispensary" — is illegal in the UK, regardless of any medical need. The legal status of prescribed CBPMs does not create any grey area for unprescribed cannabis.

CBD products sold in UK shops occupy a separate legal category. They must contain less than 1mg of THC per product and cannot be sold as medicines. Many CBD products are of inconsistent quality, with actual cannabinoid content often different from what is labelled. They are not a substitute for prescribed CBPMs.

If you believe you may benefit from medical cannabis, the correct route is through a registered specialist clinic using our directory. Self-medicating with unprescribed cannabis carries legal risk and removes any clinical oversight of dosing, interactions, and monitoring.